TY - JOUR
T1 - Infantile Disseminated Bacille Calmette–Guérin Disease with Hemophagocytosis and Mimicking Juvenile Myelomonocytic Leukemia
T2 - A Case Report with Concise Literature Review
AU - Godkhindi, Vishwapriya Mahadev
AU - Gupta, Nitin
AU - Bhat, K. Vasudeva
AU - Venkatagiri, Archana Mevalegire
N1 - Publisher Copyright:
© 2024 International Journal of Mycobacteriology | Published by Wolters Kluwer - Medknow.
PY - 2024
Y1 - 2024
N2 - Bacille Calmette–Guérin (BCG) is a live‑attenuated vaccine routinely administered to newborns to prevent severe forms of tuberculosis (TB) in TB‑endemic countries. Disseminated BCG vaccine disease is a classic feature of children with human immunodeficiency virus (HIV) or primary immunodeficiency disorders (PIDs) and is associated with high mortality. We report a case of a 6‑month‑old infant with disseminated BCG disease and hemophagocytic lymphohistiocytosis mimicking juvenile myelomonocytic leukemia with no demonstrable features of HIV or PID even after extensive laboratory work‑up and succumbed to progressive disease. Disseminated BCG disease is a rare and potentially fatal complication of BCG vaccine, and prompt immunological evaluation complemented by initiation of 4‑drug antitubercular therapy and definitive treatment with antiretroviral therapy or hematopoietic stem cell transplant is warranted.
AB - Bacille Calmette–Guérin (BCG) is a live‑attenuated vaccine routinely administered to newborns to prevent severe forms of tuberculosis (TB) in TB‑endemic countries. Disseminated BCG vaccine disease is a classic feature of children with human immunodeficiency virus (HIV) or primary immunodeficiency disorders (PIDs) and is associated with high mortality. We report a case of a 6‑month‑old infant with disseminated BCG disease and hemophagocytic lymphohistiocytosis mimicking juvenile myelomonocytic leukemia with no demonstrable features of HIV or PID even after extensive laboratory work‑up and succumbed to progressive disease. Disseminated BCG disease is a rare and potentially fatal complication of BCG vaccine, and prompt immunological evaluation complemented by initiation of 4‑drug antitubercular therapy and definitive treatment with antiretroviral therapy or hematopoietic stem cell transplant is warranted.
UR - http://www.scopus.com/inward/record.url?scp=85196726701&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85196726701&partnerID=8YFLogxK
U2 - 10.4103/ijmy.ijmy_48_24
DO - 10.4103/ijmy.ijmy_48_24
M3 - Article
AN - SCOPUS:85196726701
SN - 2212-5531
VL - 13
SP - 213
EP - 217
JO - International Journal of Mycobacteriology
JF - International Journal of Mycobacteriology
IS - 2
ER -